Document:

EX-10.11

 Exhibit 10.11 

Dec 20, 2016 
 Private & Confidential 

By Electronic Mail 
 Véronique Lecault 

Dear Véronique: 
  

	Re:	 Employment Agreement 

I am pleased to offer you full time employment with AbCellera Biologics Inc. (the “Company”). This letter agreement contains the complete
terms and conditions of your employment with the Company (the “Agreement”). 
 Your employment under this Agreement will start on
December 16, 2016 (the “Start Date”), and will continue until terminated in accordance with the provisions of this Agreement. Please review the terms of this Agreement carefully. If you wish to accept the these terms of
employment, please sign and return a copy of this agreement to Carl Hansen at                      before January 15, 2017. Please also copy
                     on this response. 
 Background
Check: Your employment under this Agreement is conditional upon the successful completion of a background check. By signing this agreement, you consent to the Company carrying out a comprehensive background check, which may include the use of
third-party service providers. If the information collected in the course of the background check would have or could have affected the Company’s decision to hire, then the Agreement will terminate without notice or compensation of any kind and
you will be paid all accrued and unpaid pay to your last day. 
 In consideration for the compensation provided under this Agreement and other good and
valuable consideration, you agree as follows: 
  

	1.	 Employment 

The terms of your employment will be as follows: 
  

	 	(a)	 Position and Responsibilities: You will be employed by the Company in the position of Lead of Finance
and Operations, reporting to the CEO or his or her designate. You will perform or fulfil all duties and responsibilities of your position, subject to applicable laws, and the duties and responsibilities that the Company may reasonably assign to you
from time to time. You will at all times conform to the reasonable and lawful instructions and directions of the Company and its managers. You will adhere to all applicable policies of the Company as established and amended from time to time. You
acknowledge and agree that as a developing company in Canada, you will need to be flexible in performing duties the Company asks you to perform from time to time, and in the position you occupy, your place of work and the person or position you
report to. As the Company changes and grows, you may be required to change the scope of your position and duties, move to another location, change your title, and/or report to a different level of management. Such changes will not involve a
reduction in compensation and you agree that no such changes will amount to a repudiation of this Agreement, constructive dismissal or termination of your employment. 

	 	(b)	 Duties: During your employment you will devote the whole of your time, attention and abilities to your
duties, which you agree to carry out faithfully, honestly, diligently and to the best of your ability. You agree to give the Company the full benefit of your knowledge, expertise, skill and ingenuity, and exercise the degree of care, diligence and
skill that a prudent professional would exercise in comparable circumstances. You may not engage in other work or business activities without the Company’s prior written consent. 

 

	 	(c)	 Base Compensation: You will earn a base salary in the amount of CAD $90,000.00 per annum, less statutory
and other required deductions, for all work and services you perform for the Company, paid to you bi-monthly in 24 equal payments, in arrears (the “Base Salary”). The Base Salary is based on a
fifty (50) hour workweek, consisting of forty (40) regular hours per week at the rate of CAD $31.49 per hour and ten (10) hours of prepaid overtime at the time-and-a-half rate of CAD $47.21 per hour. Your hours of work and schedule may change from time to time depending on operational needs, and you may be required to work evenings and weekends. You must
obtain prior approval from a manager before working any unscheduled hours. You must accurately report all unscheduled hours you work, whether approved or not, in the pay period in which you work such hours. 

 

	 	(d)	 Signing Bonus: As part of your offer you will receive a one-time
signing bonus of CAD $16,250. 

  

	 	(e)	 Overtime. You: 

 

	 	(i)	 agree to accurately record all hours worked in the manner directed by the Company on a daily basis; and

  

	 	(ii)	 are not permitted to work more than ten (10) hours per day or fifty (50) hours per week without
obtaining the prior written authorization of a manager. 

 In the event that you perform additional overtime work in excess
of the regular weekly amount (“Additional Overtime”). You are required to submit a record of the hours worked to payroll during the pay period in which the Additional Overtime was worked. 

 

	 	(f)	 Prepaid Overtime Bank. The ten (10) hours of prepaid overtime accrued by you every week will form a
prepaid overtime bank (“Paid Overtime Bank”) against which all Additional Overtime you work will be debited. Additional Overtime worked and reported by you will be debited against the Paid Overtime Bank. In the event the Paid Overtime Bank
has no accrued overtime, the Additional Overtime will be credited to you and deducted from subsequent prepaid overtime. At the end of the calendar year, the Paid Overtime Bank will be accounted for as follows: 

 

	 	(i)	 If your prepaid overtime hours exceed the actual overtime hours you worked, the deficit position in the Paid
Overtime Bank will be waived by the Company; and 

  

	 	(ii)	 If your prepaid overtime hours do not meet or exceed the actual overtime hours you worked, the Company will pay
the accrued unpaid overtime amount to you or provide you with time off in lieu. 

	 	(g)	 Probation: Given your long-time association with AbCellera, your offer is for permanent employment and
will not include any probationary period. 

  

	 	(h)	 Vacation Entitlement: You will be eligible to earn up to at least fifteen (15) days’ paid
vacation per annum, pro-rated for any partial year of employment. An unlimited number of additional paid vacation days may be approved subject to the effective execution of your duties and coordination of
responsibilities with other members of the AbCellera team. Your vacation must be taken at a time or times acceptable to the Company and in accordance with the Company’s vacation policy in effect from time to time. It is your responsibility to
schedule and take your vacation at a time or times acceptable to the Company and in accordance with the Company’s vacation policy in effect from time to time. 

 

	 	(i)	 Benefits: Effective on the Start Date, you will be eligible to participate in applicable employee
benefits plans, including the extended health and dental plan, that the Company offers its Canadian-based employees from time to time (the “Employee Benefits”). The Company reserves the right to amend, eliminate, substitute or
otherwise change the Employee Benefits at its sole discretion, at any time and without notice, including but not limited to changes to cost sharing, premium amounts, terms of benefits and deductibles. Details of the Employee Benefits will be
provided to you once in place and, thereafter, when changes are made to the Employee Benefits. 

  

	 	(j)	 Stock Options: You are eligible to earn stock options pursuant to the Company’s Incentive Stock
Option Plan as amended from time to time (the “Plan”) subject to the discretion of the Board and the terms of grant (the “Option”). As part of your starting compensation package the CEO will recommend to the Board
that you be granted a total of 200,000 stock options, with the first 33,333.33 options vesting upon the first anniversary of your employment, and the remaining 166,666,67 options vesting equally over the subsequent five year period following the
first anniversary of your employment. If approved by the Board the options will granted under the terms of the Plan. 

  

	 	(k)	 Business Expenses: The Company will reimburse you for all authorized travelling and out-of- pocket expenses actually, exclusively and necessarily incurred by you in connection with your duties under this Agreement, provided that you first furnish statements
with accompanying receipts or vouchers for all such expenses to the Company and otherwise comply with the Company’s expense policies as in effect from time to time; 

 

	 	(l)	 Travel: You will be expected to travel from time to time as business needs require in the course of
performing your duties. You will not be required to travel more than 25% time within any calendar quarter. 

  

	 	(m)	 Offer of Comparable Employment by Affiliate: You agree that if an Affiliated Company offers you
comparable employment on terms substantially similar to the terms of this Agreement, you will accept such offer and take up employment with the Affiliate of the Company. You will receive equal credit for your length of service with the Company and
all probation and benefit-qualifying periods will be waived where in the Affiliate Company’s power to do so. 

	2.	 Obligations of Employment 

In addition to your employment obligations at common law, you covenant and agree as follows: 

 

	 	(a)	 Loyalty to the Company: Throughout your employment you will well and faithfully serve the Company and
use your best efforts to promote the Business of the Company. You will act honestly and in good faith, and in the best interests of the Company. 

  

	 	(b)	 Business of the Company: You will not, during your employment with the Company, engage in any business,
enterprise or activity that is contrary to or detracts from the due performance of the Business of the Company. You will not engage in any other employment without the written consent of the Company. 

 

	 	(c)	 No Personal Benefit: You will not receive or accept for your own benefit or for any other Person’s
benefit, either directly or indirectly, any commission, rebate, discount, gratuity or profit from any Person having or proposing to have one or more business transactions with the Company, without the prior approval of the Company.

  

	 	(d)	 Business Opportunities: During your employment you will communicate and channel to the Company all
knowledge, business and customer contacts and any other information that could concern or be in any way beneficial to the Business of the Company. Any such information communicated to the Company as aforesaid will be and remain the property of the
Company notwithstanding any subsequent termination of your employment. 

  

	 	(e)	 Return of Company Property: Upon termination of your employment, or at any time upon request, you will
promptly return to the Company all Company property including all written information, tapes, discs or memory devices and copies thereof and any other material on any medium in your possession or control pertaining to the Business of the Company,
without retaining any copies or records of any Confidential Information whatsoever. You will also return any keys, pass cards, identification cards, equipment or other property belonging to the Company or the Company’s customers.

  

	 	(f)	 Pre-existing Obligations: You are hereby requested and directed
by the Company to comply with any existing common law, contractual or statutory obligations to your former employer and to any other Person. The Company is not employing you to obtain the confidential information or business opportunities of your
former employer or any other Person. 

  

	 	(g)	 Policies and Procedures: You are required to comply with the Company’s policies and procedures as
established and amended from time to time; however such policies and procedures do not form contractual terms and may be amended without notice. You are required to comply with all lawful directions of the Company, and follow all workplace policies
and procedures and with the Company’s rules, regulations, policies, practices, and procedures, as amended from time to time. 

  

	 	(h)	 Use of Company Resources: The Company’s equipment, tools and communication devices are for business
purposes only. The Company may, at any time and without further notice or consent, access, monitor and review you usage of Company information and resources, including without limitation, computers, computer software, electronic mail (including web-based email or electronic communications applications or services), instant messaging, on-line services (including the Internet), voicemail, facsimile machines, telephones
and photocopiers and any of the contents of any of the foregoing. Accordingly, you should have no expectation of privacy in connection with the use of Company resources, and your use of any of the foregoing Company resources will be regarded as your
waiver to any right to privacy in such use and your express consent to your use of resources being monitored, accessed by and reviewed by the Company. 

	 	(i)	 Legal Obligations Concerning Privacy: You agree that you will not collect, use or disclose the personal
information of any employees, contractors or customers of the Company other than as authorized in the course of your duties. You agree that you will adhere to and comply with all Company policies and laws governing the protection of personal
information. 

  

	 	(j)	 No use of Unauthorized Software: You agree that you will not download any unauthorized software onto any
Company device, nor knowingly make use of any unauthorized software in the performance of your duties. 

  

	3.	 Confidential Information 

 

	 	(a)	 Non-Disclosure of Confidential Information: At all times during
your employment and subsequent to the termination of your employment with the Company, you will keep the Confidential Information in strictest confidence and trust. You will take all necessary precautions against unauthorized disclosure of the
Confidential Information, and you will not directly or indirectly disclose, allow access to, transmit or transfer the Confidential Information to a third party, nor will you copy or reproduce the Confidential Information except as may be reasonably
required for you to perform your duties for the Company. 

  

	 	(b)	 You represent and warrant that, in performing your duties under this Agreement, you will not disclose or use
the confidential information of any other person or business in violation of the Company’s contractual or legal obligations to that other person or business. 

 

	 	(c)	 You agree to indemnify the Company for any costs, fees, expenses, damages or penalties imposed upon the Company
with respect to your willful unauthorized disclosure or misuse of such confidential information. 

  

	 	(d)	 Restricted Use of Confidential Information: 

 

	 	(i)	 At all times during and subsequent to the termination of your employment with the Company, you will not use the
Confidential Information in any manner except as reasonably required for you to perform your duties for the Company. 

  

	 	(ii)	 Without limiting your obligations under subsection 3(a), you agree that at all times during and subsequent to
the termination of your employment with the Company, you will not use or take advantage of the Confidential Information for creating, maintaining or marketing, or aiding in the creation, maintenance, marketing or selling, of any Products which are
competitive with the Products of the Company. 

  

	 	(iii)	 Upon the request of the Company, and in any event upon the termination of your employment with the Company, you
will immediately return to the Company all materials, including all copies in whatever form, containing the Confidential Information which are in your possession or under your control. 

	 	(e)	 Ownership of Confidential Information and Developments: 

 

	 	(i)	 You acknowledge and agree that you will not acquire any right, title or interest in or to the Confidential
Information or the Developments. 

  

	 	(ii)	 You agree to make full disclosure to the Company of each Development promptly after its creation. You hereby
irrevocably assign and transfer to the Company, and agree that the Company will be the exclusive owner of, all of your right, title and interest in and to each Development throughout the world, including all trade secrets, patent rights, copyrights
trademarks, industrial designs and all other intellectual property rights therein, whether realized within or beyond the scope of your employment, and regardless of the true purpose of the employment relationship, and you irrevocably waive all moral
rights you may have in these Developments. You further agree to cooperate fully at all times during and subsequent to your employment with respect to signing further documents and doing such acts and other things reasonably requested by the Company
to confirm such transfer of ownership of rights, including intellectual property rights, effective at or after the time the Development is created and to obtain patents or copyrights or the like covering the Developments. You agree that the
obligations in this section will continue beyond the termination of your employment with the Company with respect to Developments created during your employment with the Company. 

 

	 	(iii)	 You agree that the Company, its successors, its assignees and their licensees are not required to designate you
as the author of any Developments. You hereby waive in whole all moral rights which you may have in the Developments in favour of the Company, including the right to disclose the Developments to the public, retract the developments from the public,
the right to the integrity of the Developments, the right to be associated with the Developments, the right to restrain or claim damages for any distortion, mutilation or other modification of the Developments, and the right to restrain use or
reproduction of the Developments in any context and in connection with any product, service, cause or institution. In the event of having any other right in and to the Developments that cannot be assigned to the Company, you hereby unconditionally
and irrevocably waive the enforcement of all such rights, and all claims and causes of action of any kind with respect to any of the foregoing (including moral rights) against the Company, its successors, distributors, licensees, sublicensees and
customers, whether now known or hereafter to become known, and you agree, at the request and expense of the Company and its respective successors and assigns, to consent to and join in any action to enforce such rights and to procure a waiver of
such rights from the holders of such rights; 

  

	 	(iv)	 You agree, in the event of having any rights in and to the Developments that cannot be assigned to the Company
and cannot be waived, you hereby grant to the Company and its respective successors and assigns, an irrevocable, unconditional, perpetual, exclusive, worldwide, transferable, fully-paid and royalty-free license, with rights to sublicense throughout
multiple levels of sublicensees, to use in any way whatsoever the Developments and the intellectual property rights embodied therein. 

  

	 	(v)	 In performing your duties in the course of your employment with the Company, you agree to avoid designing or
developing any Development, in part or in whole, that intentionally infringes any intellectual property rights of any third party or that incorporates the intellectual property of any third party. If you become aware of any such possible
infringement in the course of your employment, you agree to immediately notify the Company in writing of all particulars of the same, Without limiting the forgoing, you agree that in working on any Development, you will not take any action that
creates any obligation on behalf of the Company to any third party, and you will not incorporate any third party or publically available software, in whole or in part, into any Development, and you will not use any such software, in whole or in
part, in a manner that may subject any Development to any license obligations of any third party. 

	4.	 Restrictive Covenants 

 

	 	(a)	 Non-Competition: You agree that while you are employed by the
Company, and for a period of 1 year following the termination of your employment with the Company, you will not, without first getting written approval from AbCellera’s board of directors, which will not be unreasonably withheld, become
engaged, directly or indirectly, as an employee, consultant, partner, principal, agent, officer, director, proprietor, shareholder (other than a holding of shares listed on a stock exchange that does not exceed 2% of the outstanding shares so
listed) or advisor, in any Competitive Business that is located or operates within Canada or the United States. 

  

	 	(b)	 Non-Solicitation of Clients: You agree that while you are
employed by the Company, and for one (1) year following the termination of your employment with the Company, you will not, directly or indirectly, contact or solicit any Clients of the Company for the purpose of selling or supplying to these
Clients of the Company any products or services which are competitive with the products or services sold or supplied by the Company at the time of your termination. The term “Client of the Company” in the preceding sentence means
any Person that: 

  

	 	(i)	 was a client of the Company at the time of the termination of your employment with the Company; or

  

	 	(ii)	 the Company actively solicited within the twelve months prior to the termination of your employment.

  

	 	(c)	 Non-Solicitation of Employees: You agree that while you are
employed by the Company, and for one (1) year following the termination of your employment with the Company , without the prior written consent of the Company, you will not directly or indirectly hire any employees of or consultants or
contractors to the Company, nor will you solicit or induce or attempt to induce any persons who are employees of or consultants to the Company to terminate their employment or consulting agreement with the Company. 

 

	5.	 Reasonableness of the Restrictive Covenants 

 

	 	(a)	 You confirm that the obligations in Section 4 are fair and reasonable, given that, among other reasons:

  

	 	(i)	 the nature of the Business is such that you could relatively easily and effectively compete with the Business,
and you therefore agree that the geographic scope of the obligation in Section 4 is reasonable; 

	 	(ii)	 the Company operates in a relatively small but highly competitive market, in which there is intense competition
from competing businesses; and 

  

	 	(iii)	 you will have access to Confidential Information concerning the Business, including information concerning the
Products and Developments and prospective Products which the Company is contemplating developing, producing, marketing, licensing or selling; 

and 
  

	 	(b)	 You agree that the obligations in Section 4, together with your other obligations under this Agreement,
are reasonably necessary for the protection of the Company’s proprietary interests, and you acknowledge and agree that your obligations contained in this Agreement will not preclude you from becoming gainfully employed in a similar capacity,
following a termination of your employment with the Company, given your training, general knowledge and experience. 

  

	6.	 Termination 

 

	 	(a)	 Resignation: If for any reason you should wish to leave the Company, you will provide the Company with
one (1) month’s prior written notice of your intention (the “Resignation Period”). The Parties hereby agree that in order to protect the Company’s interests, the Company may, in its sole and unfettered discretion,
waive the Resignation Period and end your employment immediately by delivering to you a written notice followed by payment of your Base Salary due to you during the remainder of the Resignation Period. 

 

	 	(b)	 Termination for Cause: The Company may terminate your employment at any time for Cause, effective upon
delivery by the Company to you of a written notice of termination of your employment for Cause. You will not be entitled to receive any further pay or compensation (except for pay, if any, accrued and owing under this Agreement up to the date of
termination of your employment), severance pay, notice, payment in lieu of notice, benefits or damages of any kind, and for clarity, without limiting the foregoing, you will not be entitled to any bonus or pro rata bonus payment that has not already
been awarded by the Company. 

  

	 	(c)	 Termination During Probation Period: The Company may terminate your employment at any time during the
Probation Period in accordance with Section 1(f). 

  

	 	(d)	 Termination Without Cause: After your Probation Period, the Company may terminate your employment
without cause at any time upon providing you with the greater of: 

  

	 	(i)	 written notice of the termination of your employment, or pay in lieu of notice, or a combination of notice and
pay in lieu of notice pursuant to the Employment Standards Act; or 

  

	 	(ii)	 written notice of the termination of your employment, or Base Salary in lieu of notice, or a combination of
notice and Base Salary in lieu of notice in the following amount: 

  

	 	A.	 One month for up to 24 consecutive months of employment; 

	 	B.	 Two months after 36 consecutive months of employment; or 

 

	 	C.	 Four months after 6 consecutive years of employment, plus 1 additional week for each additional year of
employment, up to a combined maximum of eight months ; 

 (the “Severance Period”) 

Any payment in lieu of the Severance Period provided to you will be inclusive of any termination or severance pay owing to you under the
Employment Standards Act and subject to statutory withholdings. You will not be entitled to receive any further pay or compensation (except for pay, if any, accrued and owing under this Agreement up to the date of termination of your
employment), and for clarity, without limiting the foregoing, you will not be entitled to any bonus or pro rata bonus payment that has not already been awarded to you by the Company. 

 

	 	(e)	 Garden Leave: Once notice of resignation or termination has been given by you or the Company, the
Company may excuse you from the performance of your duties and/or exclude you from any premises of the Company or any Affiliated Company. Base Salary and other contractual benefits shall continue to be paid or provided to you until the last day of
the notice period, subject to the terms of the governing agreements or plans. During any period where you are excused from your duties and/or excluded from the Company’s premises, you shall not, without the prior written consent of the Company,
contact (either directly or indirectly) any clients, customers, suppliers or employees of the Company or any Affiliated Company. At any time, the Company may require you to return to the Company all property in your possession or under your control
belonging to the Company or any Affiliated Company. 

  

	 	(f)	 No Implied Entitlement: Other than as expressly provided herein, you will not be entitled to receive any
further pay or compensation, severance pay, notice, payment in lieu of notice, incentives, bonuses, benefits or damages of any kind. 

  

	 	(g)	 Continued Effect: Notwithstanding any changes in the terms and conditions of your employment which may
occur in the future, including any changes in position, duties or compensation, the termination provisions in this Agreement will continue to be in effect for the duration of your employment with the Company unless otherwise amended in writing and
signed by the Company. 

  

	 	(h)	 Authorization to Deduct Debts: If, on the date you leave employment, you owe the Company any money, you
hereby authorize the Company to deduct any such debt from your final salary payment or any other payment due to you. Any remaining debt will be immediately payable to the Company and you agree to satisfy such debt within 14 days of any demand for
repayment. 

  

	7.	 Severability 

If any part, article, section, clause, paragraph or subparagraph of this Agreement is held to be indefinite, invalid, illegal or otherwise voidable or
unenforceable for any reason, the entire Agreement will not fail on the account thereof and the validity, legality and enforceability of the remaining provisions will in no way be affected or impaired thereby. Further, if any provision of this
Agreement is held by a court of competent jurisdiction to be excessively broad as to duration, activity, geography, or subject, said court will deem and interpret such provision to be valid and enforceable to the maximum duration, activity,
geographic extent, and subject permissible under applicable law. 

	8.	 Entire Agreement 

This Agreement constitutes the entire agreement between you and the Company with respect to the subject matter herein and cancels and supersedes all previous
invitations, proposals, letters, correspondence, negotiations, promises, agreements, covenants, conditions, representations and warranties with respect to the subject matter of this Agreement. There is no representation, warranty, collateral term or
condition affecting this Agreement for which any Party can be held responsible in any way, other than as expressed in writing in this Agreement. No change or modification of this Agreement will be valid unless it is in writing and signed by both
Parties. 
  

	9.	 Non-waiver 

No failure or delay by you or the Company in exercising any power or right under this Agreement will operate as a waiver of such power or right. Any consent or
waiver by any Party to this Agreement to any breach or default under this Agreement will be effective only in the specific instance and for the specific purpose for which it was given. 

 

	10.	 Survival of Terms 

The provisions of sections 2(e), 3, 4, 6(h), 7, 8, 9, 10, 11, 12, 13, 14, 15 and 16 of this Agreement will survive the termination of your employment, as well
as any other provisions herein that are necessary for the post termination protection of the Company or its Confidential Information or intellectual property. 
  

	11.	 Further Assistance 

The Parties will execute and deliver any documents and perform any acts necessary to carry out the intent of this Agreement. 

 

	12.	 Equitable Remedies 

You hereby acknowledge and agree that a breach of your obligations under this Agreement would result in damages to the Company that could not be adequately
compensated for by monetary award. Accordingly, in the event of any such breach by you, in addition to all other remedies available to the Company at law or in equity, the Company will be entitled as a matter of right to apply to a Court of
competent jurisdiction for such relief by way of restraining order, injunction, decree or otherwise, as may be appropriate to ensure compliance with the provisions of this Agreement. 

 

	13.	 Dispute Resolution 

In the event of a dispute arising out of or in connection with this Agreement, or in respect of any legal relationship associated with it or from it, which
does not involve the Company seeking a court injunction or other injunctive or equitable relief to protect its business, confidential information or intellectual property, that dispute will be resolved confidentially as follows: 

 

	 	(a)	 Amicable Negotiation – The Parties agree that, both during and after the performance of their
responsibilities under this Agreement, each of them will make bona fide efforts to resolve any disputes arising between them by amicable negotiations; 

	 	(b)	 Mediation – If the Parties are unable to negotiate resolution of a dispute, either Party may refer the
dispute to mediation by providing written notice to the other Party. If the Parties cannot agree on a mediator within thirty (30) days of receipt of the notice to mediate, then either Party may make application to the British Columbia
Arbitration and Mediation Society to have one appointed. The mediation will be held in Vancouver, BC, in accordance with the British Columbia International Commercial Arbitration Centre’s (the “BCICAC”) Commercial Mediation
Rules, and each Party will bear its own costs, including one-half share of the mediator’s fees. 

  

	 	(c)	 Arbitration – If, after mediation, the Parties have been unable to resolve a dispute and the mediator has
been inactive for more than 90 days, or such other period agreed to in writing by the Parties, either Party may refer the dispute for final and binding arbitration by providing written notice to the other Party. If the Parties cannot agree on an
arbitrator within thirty (30) days of receipt of the notice to arbitrate, then either Party may make application to the British Columbia Arbitration and Mediation Society to appoint one. The arbitration will be held in Vancouver, BC, in
accordance with the BCICAC’s Shorter Rules for Domestic Commercial Arbitration, and each Party will bear its own costs, including one-half share of the arbitrator’ s fees. 

 

	14.	 Definitions 

In this Agreement: 
  

	 	(a)	 “Affiliated Company” means an “affiliate” as defined in the Business Corporations
Act (BC) or any successor legislation, as amended from time to time. 

  

	 	(b)	 “Board” means the board of directors of the Company. 

 

	 	(c)	 “Business” means the business of discovering, researching, developing, producing,
licensing selling and marketing new antibody molecules for therapeutics, diagnostics and reagents, and such other products and services the Company offers during your employment. 

 

	 	(d)	 “Cause” includes, without limitation, breach of this Agreement and the usual meaning of cause
under the common law or the laws of British Columbia. 

  

	 	(e)	 “Competitive Business” means any business operation, whether a partnership,
proprietorship, joint venture, company or otherwise, that develops, produces, licences or markets any products or services that are competitive with the Company’s products and services in the following fields antibody discovery and antibody
product development, contract research services in antibody discovery and antibody product development, T cell analysis, and immune profiling. 

  

	 	(f)	 “Company” means AbCellera Biologics Inc., a company with an office at 305 - 2125 East Mall,
Vancouver, British Columbia V6T 1Z4, and where used in the context of protection of Confidential Information, intellectual property or the Business, “Company” includes any Affiliated Company. 

 

	 	(g)	 “Confidential Information” includes any of the following: 

 

	 	(i)	 information concerning all Products and Developments (as defined below); 

	 	(ii)	 information regarding the Company’s business, operations, financing, strategies, methods and practices,
including marketing strategies, product mix, product pricing, sales, margins, pay and compensation for staff, and any other information regarding the financial affairs of the Company; 

 

	 	(iii)	 the identity of the Company’s clients, business partners, licensees, agents and suppliers, and the nature
of the Company’s relationships with such clients, partners, licensees, agents and suppliers; 

  

	 	(iv)	 information belonging to the Company’s clients, business partners, licensees, agents and suppliers, which
is disclosed to you or the Company; and 

  

	 	(v)	 any other trade secrets or confidential or proprietary information in the possession or control of the Company,

 but does not include information which is or becomes generally available to the public through no fault of your own or
which you can establish, through written records, was in your possession prior to its disclosure to you as a result of your work for the Company. 
  

	 	(h)	 “Developments” includes all: 

 

	 	(i)	 Products, analyses, compilations, studies, concepts, software, documentation, research, data, designs, reports,
flowcharts, training materials, trade-marks, and specifications, and any related works, including any enhancements, modifications or additions to the Products owned, licensed, sold, marketed or used by the Company; 

 

	 	(ii)	 copyrightable works of authorship including, without limitation, any technical descriptions for Products, user
guides, instructions, illustrations and advertising materials; and 

  

	 	(iii)	 inventions, devices, concepts, ideas, formulae, know-how, processes,
techniques, systems, methods and improvements, 

 which are related to the companies Business or research and development
activities, whether patentable or not, developed, created, generated or reduced to practice by you, alone or jointly with others, during your employment with the Company or which result from tasks assigned to you by the Company or which result from
the use of the premises or property (including equipment, supplies of Confidential Information) owned, leased or licensed by the Company. 
  

	 	(i)	 “Parties” means, collectively, you and the Company, and for clarity, a
“Party” means any one of the Parties. 

  

	 	(j)	 “Person” means any individual, partnership, limited partnership, joint venture, syndicate,
sole proprietorship, company or company with or without share capital, unincorporated association, trust, trustee, executor, administrator or other legal personal representative, regulatory body or agency, government, or governmental agency or
entity however designated or constituted. 

	 	(k)	 “Products” means (i) any products developed by, for or on behalf of the Company for use
in its Business or operations, (ii) any intellectual property or assets owned, licensed, sold, marketed or used by the Company in connection with the Business, including enhancements, modifications, additions or other improvements to such
intellectual property; and (iii) any other products and services that the Company discovers or develops during your employment. 

  

	15.	 Conflict 

In the event of any conflict between the terms and conditions of this agreement and any other agreement, the terms of this Agreement will prevail. 

 

	16.	 Governing Laws 

This Agreement will be governed by and construed in accordance with the laws of British Columbia and the laws of Canada applicable in British Columbia. 

 

	17.	 Acknowledgement of Terms and Obligations 

You agree that you have read and understand all of the terms, rights and obligations under this Agreement, that you have had the opportunity to discuss and
negotiate these terms, rights and obligations with the Company, and that you have executed this Agreement voluntarily and of your own free will. 
  

	18.	 Counterparts 

This Agreement may be executed in two or more counterparts, each of which will be deemed to be an original and all of which will constitute one Agreement. 

 

			
	 AbCellera Biologics Inc.
  

By:

		
	    	 	/s/ Carl L. Hansen, Ph.D.
		 	 Carl L. Hansen, PhD.
 CEO &
President

 I have read, understand, acknowledge and accept the terms and conditions of my employment with the Company as set out
above: 
  

	
	
	/s/ Véronique Lecault
	Véronique Lecault

 January 1, 2019 

Private & Confidential 
 By Electronic Mail

 Veronique Lecault 
 Dear Veronique: 

 

	Re:	 Amendment of Employment Agreement to Increase Base Salary Compensation 

In recognition of your performance and excellent contributions to AbCellera, I would like to offer you an increase in your base compensation for your ongoing
employment, from CAD $150,000 per annum to CAD $180,000 per annum. 
 Effective January 1, 2019, your employment agreement will be amended as follows:

 Article 1a will be replaced with 
  

	 	(a)	 Position and Responsibilities: You will be employed by the Company in the position of Chief Operating
Officer, reporting to the CEO or his or her designate. You will perform or fulfil all duties and responsibilities of your position, subject to applicable laws, and the duties and responsibilities that the Company may reasonably assign to you from
time to time. You will at all times conform to the reasonable and lawful instructions and directions of the Company and its managers. You will adhere to all applicable policies of the Company as established and amended from time to time. You
acknowledge and agree that as a developing company in Canada, you will need to be flexible in performing duties the Company asks you to perform from time to time, and in the position you occupy, your place of work and the person or position you
report to. As the Company changes and grows, you may be required to change the scope of your position and duties, move to another location, change your title, and/or report to a different level of management. Such changes will not involve a
reduction in compensation and you agree that no such changes will amount to a repudiation of this Agreement, constructive dismissal or termination of your employment. 

Article 1c will be replaced with 
  

	 	(c)	 Base Compensation: You will earn a base salary in the amount of CAD $180,000 per annum, less statutory
and other required deductions, for all work and services you perform for the Company, paid to you bi-monthly in 24 equal payments, in arrears (the “Base Salary”). The Base Salary is based on a fifty (50) hour workweek,
consisting of forty (40) regular hours per week at the rate of CAD $62.94 per hour and ten (10) hours of prepaid overtime at the time-and-a-half rate of CAD $94.41 per hour. Your hours of work and schedule may change from time to time
depending on operational needs, and you may be required to work evenings and weekends. You must obtain prior approval from a manager before working any unscheduled hours. You must accurately report all unscheduled hours you work, whether approved or
not, in the pay period in which you work such hours. 

 Article 1n will be added 

 

	 	(n)	 Incentive Program: You will continue to be eligible to participate in the Company’s Annual Employee
Incentive Program. The incentive target for your position is 20% of Base Salary based on the Compensation Committee’s assessment of your performance and achievement of annual goals that have been approved by the Board. 

To accept this amendment please sign and return this letter to
                    . I want to sincerely express my appreciation for your work and contributions to AbCellera. 

 

					
	/s/ Carl Hansen	 		 	/s/ Véronique Lecault
	 Carl Hansen
 President & CEO
	 		 	Veronique LecaultEX-10.12

 Exhibit 10.12 

ABCELLERA BIOLOGICS INC. 

SIXTH AMENDED AND RESTATED STOCK OPTION PLAN 

Approved by the Board on November 18, 2020 
 Approved by
the Shareholders on December 1, 2020 

 TABLE OF CONTENTS 

 

							
	 ARTICLE 1 DEFINITIONS AND INTERPRETATION
	  	 	1	 
			
	 1.1
	  	 Definitions
	  	 	1	 
	 1.2
	  	 Choice of Law
	  	 	4	 
	 1.3
	  	 Headings
	  	 	4	 
		
	 ARTICLE 2 PURPOSE AND PARTICIPATION
	  	 	4	 
			
	 2.1
	  	 Purpose
	  	 	4	 
	 2.2
	  	 Participation
	  	 	4	 
	 2.3
	  	 Notification of Award
	  	 	5	 
	 2.4
	  	 Copy of Plan
	  	 	5	 
	 2.5
	  	 Limitation
	  	 	5	 
		
	 ARTICLE 3 TERMS AND CONDITIONS OF OPTIONS
	  	 	5	 
			
	 3.1
	  	 Board to Issue Common Shares
	  	 	5	 
	 3.2
	  	 Number of Common Shares
	  	 	5	 
	 3.3
	  	 Term of Option
	  	 	6	 
	 3.4
	  	 Termination
	  	 	6	 
	 3.5
	  	 Exercise Price
	  	 	9	 
	 3.6
	  	 Additional Terms
	  	 	9	 
	 3.7
	  	 Going Public Agreements
	  	 	10	 
	 3.8
	  	 Assignment of Options
	  	 	10	 
	 3.9
	  	 Adjustments
	  	 	10	 
	 3.10
	  	 Option Grant and Vesting Terms
	  	 	10	 
	 3.11
	  	 U.S. Participants
	  	 	11	 
	 3.12
	  	Australian Participants	  	 	11	 
		
	 ARTICLE 4 EXERCISE OF OPTION
	  	 	12	 
			
	 4.1
	  	 Exercise of Option
	  	 	12	 
	 4.2
	  	 Amended and Restated Voting Agreement and Amended and Restated ROFR and Co-Sale Agreement
	  	 	12	 
	 4.3
	  	 Execution of Amended and Restated Voting Agreement and Amended and Restated ROFR and Co-Sale Agreement
	  	 	12	 
	 4.4
	  	 Issue of Shares 
	  	 	12	 
	 4.5
	  	 Condition of Issue
	  	 	13	 
		
	 ARTICLE 5 ADMINISTRATION
	  	 	13	 
			
	 5.1
	  	 Administration
	  	 	13	 
	 5.2
	  	 Interpretation
	  	 	13	 
		
	 ARTICLE 6 AMENDMENT, TERMINATION AND NOTICE
	  	 	13	 
			
	 6.1
	  	 Prospective Amendment
	  	 	13	 

  
 i 

							
	 6.2
	  	 Retrospective Amendment
	  	 	13	 
	 6.3
	  	 Approvals
	  	 	14	 
	 6.4
	  	 Termination
	  	 	14	 
	 6.5
	  	 Agreement
	  	 	14	 
	 6.6
	  	 Notice
	  	 	14	 
		
	 SCHEDULE A
	  	 	A-1	 
		
	 SCHEDULE B
	  	 	B-1	 
		
	 SCHEDULE C
	  	 	C-1	 

  

  
 ii 

 SIXTH AMENDED AND RESTATED STOCK OPTION PLAN 

ARTICLE 1 

DEFINITIONS AND INTERPRETATION 
  

	1.1	 Definitions 

As used herein, unless there is something in the subject matter or context inconsistent therewith, the following terms will have the meanings set forth below:

  

	 	(a)	 “Administrator” means, initially, the President of the Company and thereafter will mean such
director or other senior officer or employee of the Company as may be designated as Administrator by the Board from time to time. 

  

	 	(b)	 “Amended and Restated ROFR and Co-Sale
Agreement” means the Amended and Restated Right of First Refusal and Co-Sale Agreement, dated as of March 23, 2020, between the Company and certain shareholders from time to time party thereto.

  

	 	(c)	 “Amended and Restated Voting Agreement” means the Amended and Restated Voting Agreement, dated
as of March 23, 2020, between the Company and certain shareholders from time to time party thereto. 

  

	 	(d)	 “Award Date” means the date on which the Board awards a particular Option or such other
effective award date determined by the Board. 

  

	 	(e)	 “Board” means the board of directors of the Company, or any committee thereof to which the
board of directors of the Company has delegated the power to administer and grant Options under the Plan. 

  

	 	(f)	 “Cause” means: 

 

	 	(i)	 Cause as such term is defined in the written employment agreement between the Company and the Option Holder; or

  

	 	(ii)	 in the event there is no written employment agreement between the Company and the Option Holder or Cause is not
defined therein, the usual meaning of just cause under the common law or the laws of the jurisdiction in which the Option Holder is employed. 

  

	 	(g)	 “Code” has the meaning given to that term under section 3.11 

 

	 	(h)	 “Common Share” or “Common Shares” means, as the case may be, one or more
common shares without par value in the capital of the Company. 

  

	 	(i)	 “Consultant” means any individual, such as a service provider pursuant to a consulting or
services agreement, as may, from time to time, be permitted or not precluded by the rules and policies of the applicable Regulatory Authorities to be granted Options. 

 

	 	(j)	 “Company” means AbCellera Biologics Inc. 

	 	(k)	 “Compensation Committee” means the compensation committee of the Company, if and as
constituted from time to time. 

  

	 	(l)	 “Convertible Shares” has the meaning given to that term under section 3.4(f).

  

	 	(m)	 “Director” means any individual holding the office of director of the Company.

  

	 	(n)	 “Employee” means any individual regularly employed on a full-time basis by the Company or any
of its subsidiaries as may, from time to time, be permitted or not precluded by the rules and policies of the applicable Regulatory Authorities to be granted Options. 

 

	 	(o)	 “Equity Securities” means: 

 

	 	(i)	 Shares or any other security of the Company that carries the residual right to participate in the earnings of
the Company and, on liquidation, dissolution or winding-up, in the assets of the Company, whether or not the security carries voting rights; 

 

	 	(ii)	 any warrants, options or rights entitling the holders thereof to purchase or acquire any such securities; or

  

	 	(iii)	 any securities issued by the Company which are convertible or exchangeable into such securities.

  

	 	(p)	 “Exercise Notice” means the notice respecting the exercise of an Option, in the form set out
as Schedule B hereto, duly executed by the Option Holder. 

  

	 	(q)	 “Exercise Period” means the period during which a particular Option may be exercised and is
the period from and including the Award Date through to and including the Expiry Date. 

  

	 	(r)	 “Exercise Price” means the price at which an Option may be exercised as determined in
accordance with section 3.5. 

  

	 	(s)	 “Expiry Date” means the date determined in accordance with section 3.4 and after which a
particular Option cannot be exercised. 

  

	 	(t)	 “Fixed Expiry Date” has the meaning given to that term under section 3.4.

  

	 	(u)	 “IPO” means the offering and sale to the public of securities of the Company in connection
with which the securities of the Company are listed or quoted on an organized trading facility. 

  

	 	(v)	 “ISO” has the meaning given to that term under section 3.11. 

 

	 	(w)	 “Market Value” means the market value of the Common Shares as determined in accordance with
section 3.5. 

  

	 	(x)	 “Option” means an option to acquire Common Shares, awarded to a Director, Employee or
Consultant under the Plan. 

  
 2 

	 	(y)	 “Option Assignor” has the meaning given to that term under section 3.4(a).

  

	 	(z)	 “Option Certificate” means the certificate, in the form set out as Schedule A hereto,
evidencing an Option. 

  

	 	(aa)	 “Option Direction” has the meaning given to that term under section 2.3.

  

	 	(bb)	 “Option Holder” means a (i) Director, Employee or Consultant, or (ii) former
Director, Employee or Consultant, or (ii) Permitted Assignee of any of the Persons referenced in clauses (i) or (ii) of this definition, in each case who holds an unexercised and unexpired Option or, where applicable, the Personal
Representative of such person. 

  

	 	(cc)	 “Permitted Assignee” means the Person identified to the Company in an Option Direction who in
all circumstances may be granted Options by the Company pursuant to a prospectus exemption under applicable securities laws and regulations, as determined by the Company to its sole satisfaction. 

 

	 	(dd)	 “Person” means any individual, partnership, joint venture, syndicate, sole proprietorship,
company or corporation with or without share capital, trust, trustee, executor, administrator, or other legal personal representatives, regulatory body or agency, government or governmental agency, authority or entity howsoever designated or
constituted. 

  

	 	(ee)	 “Personal Representative” means: 

 

	 	(i)	 in the case of a deceased Option Holder, the executor or administrator of the deceased duly appointed by a
court or public authority having jurisdiction to do so; and 

  

	 	(ii)	 in the case of an Option Holder who for any reason is unable to manage his or her affairs, the person entitled
by law to act on behalf of such Option Holder. 

  

	 	(ff)	 “Plan” means this stock option plan. 

 

	 	(gg)	 “Purchaser” has the meaning given to that term under section 3.4(f).

  

	 	(hh)	 “Regulatory Authorities” means all stock exchanges, inter-dealer quotation networks and other
organized trading facilities on which the Shares are listed and all securities commissions or similar securities regulatory bodies having jurisdiction over the Company. 

 

	 	(ii)	 “Selling Shareholders” has the meaning given to that term under section 3.4(f).

  

	 	(jj)	 “Share” or “Shares” means, as the case may be, one or more Common Shares or
shares of any other class in the share capital of the Company from time to time. 

  

	 	(kk)	 “Substantial Sale” has the meaning given to that term under section 3.4(f).

  

	 	(ll)	 “Termination Date” means: 

  
 3 

	 	(i)	 in the case of the resignation of the Option Holder’s, or Option Assignor’s, as the case may be,
employment or the termination of the Option Holder’s, or Option Assignor’s, as the case may be, consulting or service contract by the Option Holder, the date that the Option Holder or the Option Assignor, as the case may be, provides
notice of such resignation or termination to the Company; or 

  

	 	(ii)	 in the case of the termination of the Option Holder’s, or Option Assignor’s, as the case may be,
employment or consulting or service contract by the Company for any reason other than death or disability, the date that the Company delivers written notice of termination of the Option Holder’s, or Option Assignor’s, as the case may be,
employment or consulting or service contract to the Option Holder or the Option Assignor, as the case may be; or 

  

	 	(iii)	 in the case of the expiry of a fixed-term employment or consulting or service contract that is not renewed or
extended, the last day of the term. 

  

	 	(mm)	 “Transfer” includes any sale, exchange, assignment, gift, bequest, disposition, mortgage,
charge, pledge, encumbrance, grant of a security interest or other arrangement by which possession, legal title or beneficial ownership passes from one Person to another, or to the same Person in a different capacity, whether or not voluntarily and
whether or not for value, and any agreement to effect any of the foregoing, including any sale or exchange pursuant to a plan of arrangement, merger, consolidation, acquisition or similar transaction; and the words “Transferred”,
“Transferring” and similar words have corresponding meanings. 

  

	 	(nn)	 “US Participant” has the meaning given to that term under section 3.11. 

 

	1.2	 Choice of Law 

The Plan is established under, and the provisions of the Plan will be subject to and interpreted and construed in accordance with, the laws of the Province of
British Columbia. 
  

	1.3	 Headings 

The headings used herein are for convenience only and are not to affect the interpretation of the Plan. 

ARTICLE 2 
 PURPOSE
AND PARTICIPATION 
  

	2.1	 Purpose 

The purpose of the Plan is to provide the Company with a share-related mechanism to attract, retain and motivate qualified Directors, Employees and
Consultants, to reward such of those Directors, Employees and Consultants as may be awarded Options under the Plan by the Board from time to time for their contributions toward the long term goals of the Company and to enable and encourage such
Directors, Employees and Consultants to acquire Common Shares as long term investments. 
  

	2.2	 Participation 

Prior to the date immediately preceding the closing of the initial public offering of the Common Shares, the Compensation Committee will, from time to time,
recommend to the Board those Directors, Employees and Consultants, if any, to whom Options should be awarded and the Board will, from time to time and in its sole discretion, taking into account any recommendations of the Compensation Committee,
determine those Directors, Employees and Consultants, if any, to whom Options are to be awarded. Following the closing of the initial public offering of the Common Shares, the Compensation Committee and Board shall make no further grants of Options
under this Plan. 

  
 4 

	2.3	 Notification of Award 

Following the approval by the Board of the awarding of an Option, the Administrator will notify the Director, Employee and Consultant in writing of the award
and will, subject to the following sentence of this section 2.3, enclose with such notice the Option Certificate representing the Option so awarded. Upon notification of the proposed Option award by the Company but prior to the granting of such
Option, the Director, Employee or Consultant to whom the Options are to be granted may, pursuant to an irrevocable direction delivered to the Company by such Director, Employee or Consultant, in the form set out as Schedule C hereto (the
“Option Direction”), direct the Company to grant such Options to such Director’s, Employee’s or Consultant’s Permitted Assignee and to register the corresponding Option Certificate in the name of such Director’s,
Employee’s or Consultant’s Permitted Assignee. 
  

	2.4	 Copy of Plan 

Each Option Holder, concurrently with the notice of the award of the Option, will be provided with a copy of the Plan. A copy of any amendment to the Plan will
be promptly provided by the Administrator to each Option Holder. 
  

	2.5	 Limitation 

The Plan does not give any Option Holder that is a Director, nor any Option Assignor (as defined below) who is a Director, the right to serve or continue to
serve as a Director of the Company nor does it give any Option Holder that is an Employee, nor any Option Assignor who is an Employee, the right to be or to continue to be employed with the Company, nor does it give any Option Holder that is a
Consultant, nor any Option Assignor who is a Consultant, the right to have a consulting relationship with the Company or provide services to the Company. 

ARTICLE 3 
 TERMS
AND CONDITIONS OF OPTIONS 
  

	3.1	 Board to Issue Common Shares 

The Common Shares to be issued to Option Holders upon the exercise of Options will be authorized and unissued Common Shares the issuance of which will have
been authorized by the Board. 
  

	3.2	 Number of Common Shares 

Subject to adjustment as provided for in section 3.9 of the Plan, the number of Common Shares that will be available for Option Holders to acquire pursuant to
Options granted under the Plan will be the number of Common Shares allocated to previously granted Options on the date immediately preceding the closing of the initial public offering of the Common Shares. For greater certainty, if any Option
expires or otherwise terminates for any reason without having been exercised in full, the number of Common Shares in respect of which the Option was not exercised will not again be available for the purposes of the Plan. 

  
 5 

	3.3	 Term of Option 

An Option Holder may exercise an Option in whole or in part at any time or from time to time during the Exercise Period. Any Option or part thereof not
exercised within the Exercise Period will terminate and become null, void and of no effect as of 5:00 p.m. local time in Vancouver, British Columbia on the Expiry Date. 
  

	3.4	 Termination 

The Expiry Date of an Option will be the earlier of: (i) the date that is the tenth anniversary of the Award Date of such Option, or (ii) such other date so
fixed by the Board at the time the particular Option is awarded provided that such date will be no later than the tenth anniversary of the Award Date of such Option (the “Fixed Expiry Date”), or the date established, if applicable,
in subsections (a) to (f) below: 
  

	 	(a)	 Death 

In the event that the Option Holder should die while he or she is a Director (if he or she holds his or her Option as a Director) or Employee
(if he or she holds his or her Option as an Employee) or Consultant (if he or she holds his or her Option as a Consultant), the Expiry Date for any vested portion or portions of the Option will be the date that is twelve months after the date of the
Option Holder’s death. The Expiry Date for any unvested portion of the Option will be the date of the Option Holder’s death. In the event that the Option Holder is a Permitted Assignee and the Director, Employee or Consultant, as the case
may be, who delivered the Option Direction in respect of such Permitted Assignee (the “Option Assignor”) should die while he or she is a Director, Employee or Consultant, as the case may be, (i) the Expiry Date for any vested
portion or portions of such Permitted Assignee’s Option will be the date that is twelve months after the date of the death of the Option Assignor and (ii) the Expiry Date for any unvested portion of the Option will be the date of the death
of Option Assignor. 
  

	 	(b)	 Disability 

In the event that the Option Holder becomes permanently disabled while he or she is a Director (if he or she holds his or her Option as a
Director) or Employee (if he or she holds his or her Option as an Employee) or Consultant (if he or she holds his or her Option as a Consultant) and ceases to be a Director, Employee or Consultant as a result of the permanent disability, the Expiry
Date for any vested portion or portions of the Option will be the date that is six months after the date that the Option Holder ceases to be a Director, Employee or Consultant, as the case may be. The Expiry Date for any unvested portion of the
Option will be the date that the Option Holder ceases to be a Director, Employee or Consultant, as the case may be. In the event that the Option Holder is a Permitted Assignee and the Option Assignor becomes permanently disabled while he or she is a
Director, Employee or Consultant, as the case may be, and ceases to be a Director, Employee or Consultant as a result of the permanent disability, (i) the Expiry Date for any vested portion or portions of the Option will be the date that is six
months after the date that the Option Assignor ceases to be a Director, Employee or Consultant, as the case may be, and (ii) the Expiry Date for any unvested portion of the Option will be the date of the date the Option Assignor ceases to be a
Director, Employee or Consultant, as the case may be. 

  
 6 

	 	(c)	 Ceasing to Hold Office 

In the event that the Option Holder holds his or her Option as a Director of the Company and such Option Holder ceases to be a Director of the
Company, or in the event that the Option Holder is a Permitted Assignee and the Option Assignor ceases to be a Director, in either case other than by reason of death or permanent disability, the Expiry Date for any vested portion or portions of the
Option will be, unless otherwise provided for in the Option Certificate, the 90th day following the date that the Option Holder or the Option Assignor, as applicable, ceases to be a Director of the Company unless the Option Holder or the Option
Assignor, as applicable, ceases to be a Director of the Company as a result of: 
  

	 	(i)	 ceasing to meet the qualifications required under applicable laws; 

 

	 	(ii)	 being removed from office in accordance with applicable laws; or 

 

	 	(iii)	 an order made by any Regulatory Authority having jurisdiction to so order, 

in which case the Expiry Date will be the date that the Option Holder or the Option Assignor, as applicable, ceases to be a Director of the
Company. The Expiry Date for any unvested portion of the Option will be the date that the Option Holder or the Option Assignor, as applicable, ceases to be a Director of the Company. 

 

	 	(d)	 Ceasing to be an Employee or Consultant 

In the event that the Option Holder holds his or her Option as an Employee or Consultant of the Company and such Option Holder ceases to be an
Employee or Consultant of the Company, or in the event that the Option Holder is a Permitted Assignee and the Option Assignor ceases to be an Employee or Consultant of the Company, in either case other than by reason of death or permanent
disability, the Expiry Date of any vested portion or portions of the Option will be the 90th day following the Termination Date unless the Option Holder or the Option Assignor, as applicable, ceases to be an Employee or Consultant of the Company as
a result of: 
  

	 	(i)	 termination of employment for Cause (if he or she holds his or her Option as an Employee or delivered the
Option Direction in respect of such Option while an Employee of the Company, as the case may be); or 

  

	 	(ii)	 termination for failure to fulfil services pursuant to a consulting or services agreement (if he or she holds
his or her Option as a Consultant or delivered the Option Direction in respect of such Option while a Consultant of the Company, as the case may be); or 

  

	 	(iii)	 an order made by any Regulatory Authority having jurisdiction to so order, 

in which case the Expiry Date will be the Termination Date. The Expiry Date for any unvested portion of the Option will be the Termination
Date. 

  
 7 

	 	(e)	 Initial Public Offering 

Prior to completion of an IPO, the Board or the Regulatory Authorities or the underwriter may require that there be no outstanding Options and
the Company may deliver a notice to the Option Holder to this effect, in which case the unvested portion of the Option held by the Option Holder, if any, will immediately vest and the Expiry Date of the Option will be the 30th day following the date
of the notice. In the event that the Company does not complete the IPO, the Company will, to the extent reasonably practicable, grant to the Option Holder an Option equivalent (including the original vesting terms, if any) to the Option cancelled or
exercised, provided that in the case of an Option that was exercised, the Option Holder surrenders for cancellation the Common Shares acquired upon the exercise of the Option. 
  

	 	(f)	 Substantial Sale 

If security holders of the Company (the “Selling Shareholders”) have agreed to Transfer to a Person, or Persons acting jointly
or in concert, (a “Purchaser”), Equity Securities representing more than 66 2/3% of the Common Shares (a “Substantial Sale”) and the Purchaser also offers to buy the Options of an Option Holder, then the Option
Holder must sell his or her Options to the Purchaser at a price equal to: 
  

					
	 The number of Shares then Exercisable under the Option
	  	X	  	The price per Share being paid by the Purchaser to the Selling Shareholder minus the exercise price per Share under the Option

 and on otherwise similar terms and conditions as are applicable under the Substantial Sale. If the Selling
Shareholders have agreed to sell Equity Securities which are convertible into Shares only (“Convertible Shares”), the price per Share applicable in the above formula will be calculated on an as converted basis (and if there is more
than one conversion rate applicable to different classes or series of Convertible Shares outstanding, the conversion will be computed on a pro rata basis based upon the ratio of the number of Shares which holders of each class or series of
Convertible Shares may acquire to the total number of Shares which all holders of all classes and series of Convertible Shares may acquire). 

If the Purchaser offers to buy the Options of an Option Holder and the Option Holder does not sell the Option Holder’s Options to the
Purchaser as contemplated above, then that Option Holder’s Options will expire, terminate and be cancelled on completion of the Substantial Sale. 

Notwithstanding section 3.4(f) above, the Board may, in a manner no less favourable from a financial point of view to an Option Holder than the treatment
provided in section 3.4(f) above, determine the manner in which all unexercised Options granted under this Plan will be treated in the event of a Substantial Sale. 

Notwithstanding anything else contained in the Plan, the Board may in its discretion and without approval of the Company’s shareholders (a) extend
the Expiry Date of any Option, provided that in no case will an Option be exercisable later than the tenth anniversary of the Award Date of the Option; or (b) accelerate the vesting terms applicable to an Option. 

  
 8 

	3.5	 Exercise Price 

The price at which an Option Holder may purchase a Common Share upon the exercise of an Option will be as set forth in the Option Certificate issued in respect
of such Option and in any event will not be less than the Market Value of the Common Shares as of the Award Date. The Market Value of the Common Shares for a particular Award Date will be determined as follows: 

 

	 	(a)	 for each organized trading facility on which the Common Shares are listed, Market Value will be determined by a
resolution of the Board and must be either: 

  

	 	(i)	 the closing trading price of the Common Shares on the last trading day immediately preceding the Award Date; or

  

	 	(ii)	 a value that is within the parameters set by the guidelines or policies of such organized trading facility;

  

	 	(b)	 if the Common Shares trade on an organized trading facility outside of Canada, then the Market Value determined
for that organized trading facility will be converted into Canadian dollars at a conversion rate determined by the Administrator having regard for the published conversion rates as of the Award Date; 

 

	 	(c)	 if the Common Shares are listed on more than one organized trading facility, then Market Value will be the
greatest of the Market Values determined for each organized trading facility on which those Common Shares are listed as determined for each organized trading facility in accordance with subsections (a) and (b) above; 

 

	 	(d)	 if the Common Shares are listed on one or more organized trading facility but have not traded during the ten
trading day period immediately preceding the Award Date, then the Market Value will be, subject to the necessary approvals of the applicable Regulatory Authorities, such value as is determined by resolution of the Board; and 

 

	 	(e)	 if the Common Shares are not listed on any organized trading facility, then the Market Value will be, subject
to the necessary approvals of the applicable Regulatory Authorities, such value as is determined by the Board. 

 Notwithstanding anything
else contained herein, in no case will the Market Value be less than the minimum prescribed by each of the organized trading facilities as would apply to the Award Date in question. 

 

	3.6	 Additional Terms 

Subject to all applicable securities laws and regulations and the rules and policies of all applicable Regulatory Authorities, the Board may attach other terms
and conditions to the grant of a particular Option, such terms and conditions to be referred to in a schedule attached to the Option Certificate. These terms and conditions may include, but are not necessarily limited to, the following: 

 

	 	(a)	 providing that an Option expires on a date other than as provided for herein, provided that in no case will an
Option be exercisable later than the tenth anniversary of the Award Date of the Option; 

  

	 	(b)	 providing that a portion or portions of an Option vest after certain periods of time or upon the occurrence of
certain events, or expire after certain periods of time or upon the occurrence of certain events other than as provided for herein; and 

  
 9 

	 	(c)	 providing that an Option be exercisable immediately, in full, notwithstanding that it has vesting provisions,
upon the occurrence of certain events, such as a friendly or hostile takeover bid for the Company. 

  

	3.7	 Going Public Agreements 

If the Company proceeds to list its Shares on a public stock exchange or commences a public offering, each Option Holder will promptly enter into all such
escrow, pooling or other agreements as are required by the securities regulatory authorities, the exchange, the agents or the underwriters in connection with such listing or public offering. 

 

	3.8	 Assignment of Options 

Options may not be assigned or transferred, provided however that the Personal Representative of an Option Holder may, to the extent permitted by
section 4.1, exercise the Option within the Exercise Period. Notwithstanding the foregoing, nothing in this section 3.8 shall (i) restrict a Director, Employee or Consultant from delivering an Option Direction to the Company or
(ii) prohibit the Company from granting the Option referenced in such Option Direction to such Director’s, Employee’s or Consultant’s Permitted Assignee and from registering the corresponding Option Certificate in the name of
such Director’s, Employee’s or Consultant’s Permitted Assignee, in each case as contemplated in section 2.3. 
  

	3.9	 Adjustments 

If prior to the complete exercise of an Option the Common Shares are consolidated, subdivided, converted, exchanged or reclassified or in any way substituted
for (collectively, the “Event”), an Option, to the extent that it has not been exercised, will be adjusted by the Board in accordance with such Event in the manner the Board deems appropriate. No fractional Common Shares will be
issued upon the exercise of an Option and accordingly, if as a result of the Event, an Option Holder would become entitled to a fractional Common Share, such Option Holder will have the right to purchase only the next lowest whole number of Common
Shares and no payment or other adjustment will be made with respect to the fractional interest so disregarded. 
  

	3.10	 Option Grant and Vesting Terms 

Unless otherwise determined by the Board in accordance with the terms and conditions of this Plan, Options will be granted by the Board and an Option granted
to an Option Holder will vest over a three year period of which one-quarter of such Option will vest immediately and of the remaining unvested options will vest in equal portions over three years such that one-third will vest on the first, second and third anniversary of the Award Date. 
 For clarity, the Board may deviate
from the terms of this section 3.10 with respect to the grant of Options provided that such grant is made in accordance with the other terms of this Plan. 

Unless otherwise determined by the Board in accordance with the terms and conditions of this Plan and subject to applicable laws, the vesting schedule for an
Option Holder’s Option shall be suspended during (a) any leave of absence taken by the Option Holder or the Option Assignor, as the case may be, that is approved by the Company or (b) any statutory-protected leave of absence taken by
the Option Holder or the Option Holder, as the case may be. Upon expiration of any such leave of absence, the vesting schedule for such Option shall recommence and any applicable vesting dates for such Option shall be recalculated based on the
length of such leave of absence. 

  
 10 

	3.11	 U.S. Participants 

Any Option granted under the Plan to an Option Holder who is a citizen or resident of the United States (including its territories, possessions and all areas
subject to the jurisdiction) (a “U.S. Participant”) may be an incentive stock option (an “ISO”) within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended, of the United States (the
“Code”), but only if so designated by the Company in the agreement evidencing such Option. No provision of this Plan, as it may be applied to a U.S. Participant with respect to Options which are designated as ISOs, shall be
construed so as to be inconsistent with any provision of Section 422 of the Code or the Treasury Regulations thereunder. Grants of Options to U.S. Participants which are not designated as or otherwise do not qualify as ISOs will be treated as
nonstatutory stock options for U.S. federal tax purposes. Notwithstanding anything in this Plan contained to the contrary, the following provisions shall apply to ISOs granted to each U.S. Participant: 

 

	 	(a)	 ISOs shall only be granted to individual U.S. Participants who are, at the time of grant, employees of the
Company within the meaning of the Code. Any Director who is a U.S. Participant shall be ineligible to vote upon the granting of such Option; 

  

	 	(b)	 the aggregate fair market value (determined as of the time an ISO is granted) of the Common Shares subject to
ISOs exercisable for the first time by a U.S. Participant during any calendar year under this Plan and all other stock option plans, within the meaning of Section 422 of the Code, of the Company shall not exceed One Hundred Thousand Dollars in
U.S. funds (U.S.$100,000); 

  

	 	(c)	 the Exercise Price for Common Shares under each ISO granted to a U.S. Participant pursuant to this Plan shall
be not less than fair market value of such Common Shares at the time the Option is granted, as determined in good faith by the Board at such time (unless such ISO is granted pursuant to an assumption or substitution for another option in a manner
satisfying the provisions of Section 424(a) of the Code); 

  

	 	(d)	 if any U.S. Participant to whom an ISO is to be granted under the Plan at the time of the grant of such ISO is
the owner of shares possessing more than ten percent (10%) of the total combined voting power of all classes of shares of the Company, then the following special provisions shall be applicable to the ISO granted to such individual:

  

	 	(i)	 the Exercise Price (per Common Share) subject to such ISO shall not be less than one hundred ten percent (110%)
of the fair market value of one Common Share at the time of grant; and 

  

	 	(ii)	 for the purposes of this section 3.11 only, the Exercise Period shall not exceed five (5) years from the
date of grant; 

  

	 	(e)	 no ISO may be granted hereunder to a U.S. Participant following the expiration of ten (10) years after the
date on which this Plan is adopted by the Company or the date on which the Plan is approved by the shareholders of the Company, whichever is earlier; and 

  

	 	(f)	 no ISO granted to a U.S. Participant under the Plan shall become exercisable unless and until the Plan shall
have been approved by the shareholders of the Company. 

  

	3.12	 Australian Participants 

For purposes of any Option granted under the Plan to a grantee who is a resident of Australia or subject to taxation in Australia under the Income Tax
Assessment Act 1997 (Cth) (an “Australian Participant”), it is stated that Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) (the “Income Tax Assessment Act”) applies to any grants of Options under the
Plan (subject to the requirements of that Income Tax Assessment Act), such that Options granted to Australian participants are intended to qualify for deferred taxation under that Subdivision. 

  
 11 

 ARTICLE 4 

EXERCISE OF OPTION 
  

	4.1	 Exercise of Option 

An Option may be exercised only by the Option Holder or the Personal Representative of the Option Holder. An Option Holder or the Personal Representative of
the Option Holder may exercise the vested portion or portions of an Option in whole or in part at any time or from time to time during the Exercise Period up to 5:00 p.m. local time in Vancouver, British Columbia on the Expiry Date by delivering to
the Administrator an Exercise Notice, the applicable Option Certificate and a certified cheque or bank draft payable to “AbCellera Biologics Inc.” in an amount equal to the aggregate Exercise Price of the Common Shares to be
purchased pursuant to the exercise of the Option. 
  

	4.2	 Amended and Restated Voting Agreement and Amended and Restated ROFR and
Co-Sale Agreement 

 It is a condition of the Plan that an Option Holder who wishes to exercise
an Option in whole or in part prior to the completion of an IPO must, if required by the Board, be a party to the Amended and Restated Voting Agreement, the Amended and Restated ROFR and Co-Sale Agreement, or
any other agreement, instrument or document to which any of the Company’s shareholders are party and which relate to rights and obligations with respect to the holding or sale of Common Shares, by executing a joinder agreement substantially in
the form provided by the Company. The Amended and Restated Voting Agreement and Amended and Restated ROFR and Co-Sale Agreement establish certain rights and obligations with respect to the holding and sale of
all Common Shares purchased from time to time by the Option Holder upon the exercise of Options. 
  

	4.3	 Execution of Amended and Restated Voting Agreement and Amended and Restated ROFR and Co-Sale Agreement 

 Prior to the completion of an IPO, as soon as practicable following the receipt
of the Exercise Notice, the Administrator will establish whether the Option Holder is a party to the Amended and Restated Voting Agreement, the Amended and Restated ROFR and Co-Sale Agreement or any other
agreement, instrument or document to which any of the Company’s shareholders are party and which relate to rights and obligations with respect to the holding or sale of Common Shares. If the Option Holder is not a party to the Amended and
Restated Voting Agreement, the Amended and Restated ROFR and Co-Sale Agreement, or any other agreement, instrument or document to which any of the Company’s shareholders are party and which relate to
rights and obligations with respect to the holding or sale of Common Shares, and if so required by the Board, the Administrator will cause to be delivered to the Option Holder a joinder agreement substantially in the form provided by the Company for
execution by the Option Holder and return to the Administrator. 
  

	4.4	 Issue of Shares 

As soon as practicable following the receipt of the Exercise Notice, the Administrator will, in his sole discretion, cause to be delivered to the Option Holder
a certificate for the Common Shares purchased by the Option Holder or a copy of such certificate and the original of such certificate will be placed in the minute book of the Company or cause to be delivered to the Option Holder other evidence of
ownership of such Common Shares. If the number of Common Shares in respect of which the Option was exercised is less than the number of Common Shares subject to the Option Certificate surrendered, the Administrator will forward a new Option
Certificate to the Option Holder concurrently with delivery of the share certificate or other evidence of ownership of Common Shares for the balance of the Common Shares available under the Option. 

  
 12 

	4.5	 Condition of Issue 

The Options and the issue of Common Shares by the Company pursuant to the exercise of Options are subject to the terms and conditions of the Plan and
compliance with the rules and policies of all applicable Regulatory Authorities with respect to the granting of such Options and the issuance and distribution of such Common Shares, and to all applicable securities laws and regulations. The Option
Holder agrees to comply with all such laws, regulations, rules and policies and agrees to furnish to the Company any information, reports or undertakings required to comply with, and to fully cooperate with, the Company in complying with such laws,
regulations, rules and policies. 
 ARTICLE 5 

ADMINISTRATION 
  

	5.1	 Administration 

The Plan will be administered by the Administrator on the instructions of the Board. The Compensation Committee may, from time to time, recommend to the Board
how the Plan should be administered. The Board may make, amend and repeal at any time and from time to time such policies not inconsistent with the Plan as it may deem necessary or advisable for the proper administration and operation of the Plan
and such policies will form part of the Plan. The Board may delegate to the Administrator or any director, officer or employee of the Company such administrative duties and powers as it may see fit. 

 

	5.2	 Interpretation 

The interpretation by the Board of any of the provisions of the Plan and any determination by it pursuant thereto will be final and conclusive and will not be
subject to any dispute by any Option Holder. No member of the Board or any person acting pursuant to authority delegated by it hereunder will be liable for any action or determination in connection with the Plan made or taken in good faith and each
member of the Board and each such person will be entitled to indemnification with respect to any such action or determination in the manner provided for by the Company. 

ARTICLE 6 

AMENDMENT, TERMINATION AND NOTICE 
  

	6.1	 Prospective Amendment 

The Board may, from time to time and in accordance with any third party obligations of the Company, amend the Plan and the terms and conditions of any Option
thereafter to be granted and, without limiting the generality of the foregoing, may make such amendment for the purpose of meeting any changes in any relevant law, rule or regulation applicable to the Plan, any Option or the Common Shares, or for
any other purpose which may be permitted by all relevant laws, regulations, rules and policies provided always that any such amendment (with the exception of an amendment pursuant to section 3.4(f)) will not alter the terms or conditions of any
Option or impair any right of any Option Holder pursuant to any Option awarded prior to such amendment. 
  

	6.2	 Retrospective Amendment 

The Board may from time to time retrospectively amend the Plan and, with the consent of the affected Option Holders, retrospectively amend the terms and
conditions of any Options which have been previously granted. 

  
 13 

	6.3	 Approvals 

The Plan and any amendments hereto are subject to all necessary approvals of the applicable Regulatory Authorities. 

 

	6.4	 Termination 

The Board may terminate the Plan at any time provided that such termination will not alter the terms or conditions of any Option or impair any right of any
Option Holder pursuant to any Option awarded prior to the date of such termination which will continue to be governed by the provisions of the Plan. 
  

	6.5	 Agreement 

The Company and every Option awarded hereunder will be bound by and subject to the terms and conditions of the Plan. By accepting an Option granted hereunder,
the Option Holder has expressly agreed with the Company to be bound by the terms and conditions of the Plan. 
  

	6.6	 Notice 

All notices, requests, demands and other communications required or permitted to be given under this Plan and the Options granted under this Plan shall be in
writing and shall be either served personally on the party to whom notice is to be given, in which case notice shall be deemed to have been duly given on the date of such service; emailed, in which case notice shall be deemed to have been given on
the date the email was sent; faxed, in which case notice shall be deemed to have been duly given on the date the fax is sent; or mailed to the party to whom notice is to be given, by first class mail, registered or certified, return receipt
requested, postage prepaid, and addressed to the party at his or its most recent known address, in which case such notice shall be deemed to have been duly given on the tenth postal delivery day following the date of such mailing. 

  
 14 

 SCHEDULE A 

ABCELLERA BIOLOGICS INC. 

SIXTH AMENDED AND RESTATED STOCK OPTION PLAN 

OPTION CERTIFICATE 
 This Certificate is
issued pursuant to the provisions of the AbCellera Biologics Inc. (the “Company”) sixth amended and restated stock option plan (the “Plan”) and evidences that ● is the holder (the “Option
Holder”) of an option (the “Option”) to purchase up to ● Common Shares Without Par Value (the “Common Shares”) in the capital stock of the Company. The Exercise Price of the Option is Cdn. $●
per Common Share. 
 Subject to the provisions of the Plan: 
  

	 	(a)	 the Award Date of the Option is ●, ●; and 

 

	 	(b)	 the Fixed Expiry Date of the Option is ●, ●. 

The vested portion or portions of the Option may be exercised at any time and from time to time from and including the Award Date through to 5:00 p.m. local
time in Vancouver, British Columbia on the Expiry Date by delivering to the Administrator of the Plan an Exercise Notice, in the form provided in the Plan, together with this Certificate and a certified cheque or bank draft payable to
“AbCellera Biologics Inc.” in an amount equal to the aggregate of the Exercise Price of the Common Shares in respect of which the Option is being exercised. 

Upon receiving the Exercise Notice, the Administrator may deliver a joinder agreement substantially in the form provided by the Company to the Option Holder.
The Option and the issue of Common Shares by the Company pursuant to the exercise of the Option are subject to the Option Holder signing and returning to the Administrator a copy of the joinder agreement, if so required by the Administrator. 

This Certificate and the Option evidenced hereby are not assignable, transferable or negotiable and are subject to the detailed terms and conditions contained
in the Plan, the terms and conditions of which the Option Holder hereby expressly agrees with the Company to be bound by. This Certificate is issued for convenience only and in the case of any dispute with regard to any matter in respect hereof, the
provisions of the Plan and the records of the Company will prevail. 
 The Option is also subject to the terms and conditions contained in the schedules, if
any, attached hereto. All terms not otherwise defined in this Certificate will have the meanings given to them under the Plan. 
 Dated this ● day of
●, ●. 
  

			
	ABCELLERA BIOLOGICS INC. 
		
	Per:	 	 
		 	Administrator, Stock Option Plan 
AbCellera Biologics Inc.

  
 A-1 

 OPTION CERTIFICATE—SCHEDULE 

The additional terms and conditions attached to the Option represented by this Certificate are as follows: 

 

	1.	 ●; and 

  

	2.	 ●. 

  

			
	ABCELLERA BIOLOGICS INC. 
		
	Per:	 	 
		 	Administrator, Stock Option Plan 
AbCellera Biologics Inc.

  
 A-2 

 SCHEDULE B 

ABCELLERA BIOLOGICS INC. 

SIXTH AMENDED AND RESTATED STOCK OPTION PLAN 

NOTICE OF EXERCISE OF OPTION 
  

	TO:	 The Administrator, Stock Option Plan 

AbCellera Biologics Inc. 
 2215
Yukon Street 
 Vancouver, British Columbia, V5Y 0A1 

The undersigned hereby irrevocably gives notice, pursuant to the AbCellera Biologics Inc. sixth amended and restated stock option plan (the
“Plan”), of the exercise of the Option to acquire and hereby subscribes for (cross out inapplicable item): 
  

	 	(a)	 all of the Common Shares; or 

 

	 	(b)	 ___________________ of the Common Shares, 

which are the subject of the Option Certificate attached hereto. 

The undersigned tenders herewith a certified cheque or bank draft (circle one) payable to “AbCellera Biologics Inc.” in an amount equal to
the aggregate Exercise Price of the aforesaid Common Shares and directs the Company to issue the certificate evidencing said Common Shares in the name of the undersigned to be mailed to the undersigned at the following address: 

__________________________________ 

__________________________________ 

__________________________________ 
 The
undersigned acknowledges that upon receiving the Exercise Notice, the Administrator may deliver a joinder agreement substantially in the form provided by the Company to the undersigned. The Option and the issue of Common Shares by the Company
pursuant to the exercise of the Option are subject to the undersigned signing and returning to the Administrator a copy of the joinder agreement, if so required by the Administrator. 

By executing this Notice of Exercise of Option the undersigned hereby confirms that the undersigned has read the Plan and agrees to be bound by the provisions
of the Plan, including without limitation section 4.2. All terms not otherwise defined in this Notice of Exercise of Option will have the meanings given to them under the Option Certificate. 

DATED the ________ day of ____________________, __________. 

__________________________________ 
 Signature of Option
Holder 

  
 B-1 

 SCHEDULE C 

FORM OF OPTION DIRECTION 

IRREVOCABLE OPTION DIRECTION 

(this “Direction”) 
  

	TO:	 AbCellera Biologics Inc. (the “Company”) 

 
  

Reference is made herein to the Company’s sixth amended and restated stock option plan, as amended, restated, modified and supplemented from time to time
(the “Plan”). All capitalized terms used but not defined herein shall have the meaning ascribed to such term as set out in the Plan. 

This Direction constitutes an Option Direction under the Plan. 

Pursuant to section 2.3 of the Plan, the Company is hereby irrevocably directed to grant the following Option as follows: 

 

							
	 Name of Permitted

Assignee
	  	
Address for

Registration
	  	
Number of

Options
	  	Delivery Instructions
	 [•]
	  	
[•]
	  	
[•]
	  	
[•]

 The undersigned hereby confirms to the Company that the grantee of the Option set forth above is a Permitted Assignee. 

[Remainder of page intentionally left blank – signature on following page] 

  
 C-1 

 DATED the ________ day of ____________________, __________. 

__________________________________ 
 [Signature of
Option Assignor] 

  
 C-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]